PRE
HEALTHCAREPrenetics Global Ltd - Class A
Live · NASDAQ · May 9, Close
What's Moving PRE Today?
No stock-specific AI insight has been generated for PRE yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$15.90
Fundamentals
Trading
PRE News
20 articles- Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference CallYahoo Finance·May 8, 2026
- Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year PartnershipYahoo Finance·May 7, 2026
- Top Growth Companies With Insider Stakes In April 2026Yahoo Finance·Apr 27, 2026
- Pensana banks $15m tranche from Cascade as it advances Longonjo rare earth projectProactive Investors·Apr 17, 2026
- Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year OneYahoo Finance·Apr 14, 2026
- Initiating Coverage of Rapid-Growing PREYahoo Finance·Apr 8, 2026
- Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year PartnershipYahoo Finance·Apr 2, 2026
- Prenetics Global (PRE) Partners with Superpower on Diagnostics and SupplementsYahoo Finance·Apr 1, 2026
- Prenetics' IM8 Partners with Superpower to Personalize the Future of SupplementationYahoo Finance·Mar 24, 2026
- Prenetics Global Conference: CEO Danny Yeung details IM8’s $100M ARR surge with David BeckhamMarketbeat·Mar 24, 2026
- Prenetics Global Conference: CEO Pivots to IM8, Targets $200M 2026 Sales and $40M BuybackMarketbeat·Mar 24, 2026
- Prenetics Global CEO Touts IM8 Breakout Growth, Guides $180M-$200M Revenue at ConferenceMarketbeat·Mar 21, 2026
- Prenetics to Participate in the 38th Annual ROTH ConferenceYahoo Finance·Mar 18, 2026
- Sidoti Events, LLC's March Small-Cap Virtual ConferenceYahoo Finance·Mar 18, 2026
- Prenetics Authorizes $40 Million Share Repurchase ProgramYahoo Finance·Mar 6, 2026
- Prenetics Global (PRE) Reports 480% Revenue Surge Driven by IM8 Brand LaunchYahoo Finance·Mar 4, 2026
- Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 MillionYahoo Finance·Mar 3, 2026
- Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New FlavoursYahoo Finance·Feb 23, 2026
- Prenetics Global Limited Q4 2025 Earnings Call SummaryMoby·Feb 19, 2026
- Sector Update: Health Care Stocks Decline Late AfternoonYahoo Finance·Feb 18, 2026
All 20 articles loaded
Price Data
52-Week Range
$15.90
Fundamentals
Trading
About Prenetics Global Ltd - Class A
Prenetics Global Ltd (PRE) is a premier health technology innovator focused on delivering advanced genetic and diagnostic testing solutions that empower consumers and healthcare professionals with critical health insights. With a diverse portfolio of state-of-the-art testing services and integrated digital health offerings, the company has seen significant international growth, fueled by strategic partnerships and a strong commitment to ongoing research and development. As a frontrunner in the personalized medicine space, Prenetics is ideally positioned to capitalize on the increasing demand for accessible and actionable health information, representing a compelling investment opportunity in the dynamic healthcare landscape.